BD Reports Mixed Earnings for Second Quarter

BD reported quarterly revenues of $1.741 billion for the second fiscal quarter ended March 31, which was a decrease of 0.4 percent from the prior year period. The company’s diagnostics division had revenues of $540 million, an increase of 2 percent from the prior year period after accounting for an estimated 3 percentage points of unfavorable impact from foreign currency translation. Increased sales of safety-engineered devices, cancer diagnostics and infectious disease testing systems were partially offset by a decline in sales of flu testing products because of a mild U.S. flu season, the company says in a statement.